Calvin Ross

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
Calvin Ross

Calvin Ross was the founder, research and development director of Norwich Pharma and ProtoPharma. He was also the inventor and developer of novel pharmexeutical products for international markets, and was responsible for the development and clinical trials for the sublingual anti-malarial treatment for children - ArTiMist. Mr Ross passed away in 2010.

Lists and Charts

Total Shareholder Return as at 05/02/26

Rank Company 1 Yr 5 Yr
1561st Kuniko -54.57% 0%
1562nd Coventry Group -54.59% -12.38%
1563rd Arovella Therapeutics -54.74% 14.87%
1564th HMC Capital Limited -54.86% 3.15%
1565th Australian Dairy Nutritionals Group -55.16% -13.11%
View Full List
1663 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Related Information

X